Cardiovascular Pharmacology: Endothelial Control, Vol 60. Advances in Pharmacology

  • ID: 1757948
  • Book
  • 336 Pages
  • Elsevier Science and Technology
1 of 4

Cardiovascular disease remains a major cause of death and disability in developed countries and, increasingly so, in the developing world. Presented in this volume of Advances in Pharmacology are some of the most promising possibilities for treating large numbers of individuals afflicted with these conditions.

  • Contains up-to-date reviews of the most important emerging cardiovascular therapies written by world leaders in the field

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 4

1. The Cardiovascular Physiology and Pharmacology of Endothelin-1 2. Vascular Pharmacology of Epoxyeicosarienoic Acids 3. Prostaglandins in Action: Indispensable Roles of Cyclooxygenase-1 and 2 in Endothelium-dependent Contractions 4. TP Receptors and Oxidative Stress: Hand in Hand from Endothelial Dysfunction to Atherosclerosis 5. Regulation of Endothelial Cell Tetrahydrobiopterin: Pathophysiological and Therapeutic Implications 6. Polyphenol-Induced Endothelium-Dependent Relaxations: Role of NO and EDHF 7. Organic Nitrates and Nitrate Tolerance
State of the Art and Future Developments 8. Vascular Actions of Adipokines: Molecular Mechanism and Therapeutic Intervention 9. Cardiovascular Effects of Erythropoietin: An Update

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Vanhoutte, Paul.

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll